Gil Breiman is actively involved with the innovation ecosystem, representing investors and entrepreneurs launching, growing, and exiting innovative businesses in a broad spectrum of high technology and life sciences fields. He regularly advises clients on international expansion in establishing and expanding overseas business.

Gil represents entrepreneurs, corporations, and investors in all phases of the business cycle, from incorporation to financing (angel, strategic, non-dilutive, venture capital, private equity) to business development and growth, and mergers and acquisitions (“M&A”). Gil has been involved in funds formation and various investment vehicles.

Gil has represented numerous companies and individuals from various countries in cross-border transactions, M&A, sales channel setups, and operations.

His clients appreciate personal, responsive, and business-oriented advice, problem-solving abilities, and practical solutions to help them achieve their goals and grow their businesses.

Gil represents groups that finance and acquire commercial real estate buildings and related assets. Those financings involve various complex international and U.S. structuring and financing matters. He also represents and advises sellers and buyers of medical practices, helping medical professionals in business transitions, expansions, and ongoing business matters.

Gil has extensive experience representing companies and individuals engaging in business between the United States and Israel and has represented government agencies in America.

Gil has been quoted and published articles in several publications and invited to speak at venture capital and emerging company conferences and academic settings on issues pertaining to entrepreneurship, investments, and international business.